These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23475624)

  • 1. Diagnostic and treatment of adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Thomas X; Heiblig M
    Int J Hematol Oncol; 2016 Sep; 5(2):77-90. PubMed ID: 30302206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
    Fielding AK; Rowe JM; Buck G; Foroni L; Gerrard G; Litzow MR; Lazarus H; Luger SM; Marks DI; McMillan AK; Moorman AV; Patel B; Paietta E; Tallman MS; Goldstone AH
    Blood; 2014 Feb; 123(6):843-50. PubMed ID: 24277073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus.
    Couban S; Savoie L; Mourad YA; Leber B; Minden M; Turner R; Palada V; Shehata N; Christofides A; Lachance S
    Curr Oncol; 2014 Apr; 21(2):e265-309. PubMed ID: 24764712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
    Nardi V; McAfee SL; Dal Cin P; Tsai HK; Amrein PC; Hobbs GS; Brunner AM; Narayan R; Foster J; Fathi AT; Hock H
    Oncologist; 2022 Mar; 27(2):82-86. PubMed ID: 35641210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab.
    Litzow MR
    Immunotargets Ther; 2014; 3():79-89. PubMed ID: 27471701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.
    Dasgupta Y; Koptyra M; Hoser G; Kantekure K; Roy D; Gornicka B; Nieborowska-Skorska M; Bolton-Gillespie E; Cerny-Reiterer S; Müschen M; Valent P; Wasik MA; Richardson C; Hantschel O; van der Kuip H; Stoklosa T; Skorski T
    Blood; 2016 Apr; 127(17):2131-43. PubMed ID: 26864341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges.
    Soverini S; Bassan R; Lion T
    J Hematol Oncol; 2019 Apr; 12(1):39. PubMed ID: 31014376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK; Zakout GA
    Curr Hematol Malig Rep; 2013 Jun; 8(2):98-108. PubMed ID: 23475624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.
    Jabbour E; Kantarjian H
    Am J Hematol; 2018 Mar; 93(3):442-459. PubMed ID: 29411417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
    Osman AEG; Deininger MW
    Blood Rev; 2021 Sep; 49():100825. PubMed ID: 33773846
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.